| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-102 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08 |
| filingDate |
2009-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_368eef4634f5ab3f4c08f06582258a24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_164a6898ea31ee6f528a0405ff75814b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28cb6df164ee05c7fa31c3298d053451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38d6570143f3c3fbfeadede011c9b1c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_038a2fc237325e712533b6b50a73627d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9945ec9b3a26e4ef43b9ce9cd0e5cb26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c517a934a7175691f69352407a1651e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9178629e602e9cd693530673bb8b2c7a |
| publicationDate |
2012-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-586590-A |
| titleOfInvention |
Insulin analogues or derivatives having an extremely delayed time-action profile |
| abstract |
Discloses insulin analogues with the general structure as shown in Formula 1 with amino acid substitutions in the A-chain and B-chain as disclosed. Further discloses a method for preparing the insulin analogues. Also discloses insulin analogues which further comprise an addition of a glucagon-like peptide-1 or extendin-3 or -4 molecule. The therapeutic application is in the treatment of diabetes by providing insulin analogues with long-lasting activity in vivo. |
| priorityDate |
2008-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |